In hippocampal tissue donated by people whose average age was over 80, a few cells still carry the molecular profile of immature neurons. They are rare enough that the team who found them had to develop new ways of locating them, and they appeared in all three groups of donors studied: people without brain pathology, people with Alzheimer’s disease, and people whose brains held Alzheimer’s pathology yet who stayed resilient to dementia.
The tech news worth your time: 400,000+ professionals from Google, Apple and OpenAI read Techpresso, a daily email with the most interesting tech news and insights.
We may earn a commission if you sign up.
The cells’ behaviour differed between groups more than their numbers did, and the work comes with a plain limit: it describes post-mortem tissue.
Donated tissue and three groups
The Netherlands Institute for Neuroscience described the work in a release dated 24 April 2026. The paper itself appeared in the May 2026 issue of Cell Stem Cell, volume 33, issue 5, starting on page 763, published as “Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer’s pathology and cognitive resilience.” Giorgia Tosoni, a PhD student in the lab, led the work, and Evgenia Salta is the senior author. The aggregator ScienceDaily carried the findings again on 27 October 2026, roughly six months after the Dutch release.
The tissue came from the Netherlands Brain Bank, and the team zoomed in on a small part of the brain’s memory centre. According to the abstract record, the method was single-nucleus RNA sequencing, which reads the active genes in individual cell nuclei. The release does not say how many donors or nuclei were in each group, and neither does the abstract; those counts sit in the full text, which Cell Press does not serve to automated readers.
Why resilience is the puzzle
Salta framed the motivation in numbers and in uncertainty. Around 30 percent of older adults who develop Alzheimer’s disease never experience its symptoms, she said, adding that the reason is still unknown. That’s a big mystery, and a very important one.” The group of resilient donors is the point of the design. Their brains show the pathology and they were cognitively healthy anyway, so comparing them with donors who developed dementia isolates something other than the presence of the disease itself.
Behind the design sits an old argument. As News-Medical’s reprint of the institute’s release puts it, the team set out to test whether resilient brains repair themselves by adding new neurons, a process called adult neurogenesis that is well established in other animals but has long been debated in humans. Because the cells are “extremely rare,” Salta said, new data analysis methods were needed to find them, built so that the search would not lean heavily on assumptions carried over from animal research.
What “immature” means in a brain past 80
The abstract opens by stating that it remains unclear whether immature neurons exist in the adult human brain at all, and what they do in neurodegenerative disease. Rodent studies suggest that adult-born hippocampal neurons play active roles in health and in Alzheimer’s models, but human data are limited. Finding cells with an immature profile, as the abstract frames it, is a statement about gene activity, and it stops short of proving that the human brain keeps making new neurons into old age.
The finding that gives the study its hook is the persistence. Even at an average age of over 80, Salta said, immature neurons were found “in all groups.” Their numbers did not differ between resilient and dementia donors as much as the team expected, which pushed attention toward what the cells were doing rather than how many there were.
Different programs in the resilient group
In resilient individuals, Salta said, the cells “seem to activate programs that help them survive and cope with damage,” and the data also show lower signals related to inflammation and cell death. The abstract states that the cells’ profiles reflect “juvenile” functions that appear compromised in Alzheimer’s disease, and the authors suggest the cells may help maintain balance in the aged hippocampus and contribute to cognitive resilience. Salta offered one image: the cells may act “as a sort of fertilizer in a garden that has started falling apart,” supporting surrounding tissue rather than only replacing lost neurons.
Each of those statements is hedged by the people who made them. Salta said the cells’ function is assumed from the data and cannot be confirmed in this type of study. Post-mortem tissue captures a single moment, at death, so it cannot show whether the cells’ behaviour helped protect a brain or merely accompanied protection that came from elsewhere. The result is an association between cell profile and cognitive status. No therapy was tested, and the release makes no claim about prevention. Future work, Salta said, will examine how these neurons interact with other brain cells.
Salta described the study as “one piece of a very large puzzle,” and, as reported by Neuroscience News, she said the story “might not be (only) about replacing lost neurons.” Her broader verdict on the field is the closest thing the work offers to a conclusion: “There will never be just one factor that explains resilience.”
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
The tech news worth your time: Subscribe to Techpresso →
We may earn a commission if you sign up.
More from Morning Overview
- Two passengers died at an Ohio toll plaza, and the NTSB now wants the cash lanes shut
- Long use of a common prostate pill is tied to a higher chance of glaucoma
- Ford is recalling 223,472 F-150 pickups because the fuel tank can leak or detach
- Hybrids have 15% fewer problems than gas cars, while EVs and plug-in hybrids have about 80% more, Consumer Reports finds
